Medilink Therapeutics (suzhou) Co., Ltd.

This clinical trial is testing a new drug called YL201 in people with advanced solid tumors that have spread. The study aims to find the safest and most effective dose and see if the drug can shrink tumors or slow their growth. It will involve about 990 adults with specific cance…